Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Andrew E Epstein Added: 3 years ago
Atrial fibrillation (AF) is the most commonly sustained cardiac arrhythmia observed in clinical practice with a prevalence of over 2,200,000 adults in the US. The prevalence of AF increases with age, from <1% among persons <60 years of age, to approximately 10% among those aged ÔëÑ80 years. AF is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality… View more
Author(s): Jennifer Franke , Horst Sievert Added: 3 years ago
After having performed angioplasty in coronary and peripheral vascular disease with excellent results, carotid angioplasty was thought to be an opportunity to simplify the treatment of carotid stenosis. Up until then there was no apparent reason to protect patients against distal embolisation. With the development of carotid angioplasty and stenting, prevention of distal embolisation of… View more
Author(s): Andrew E Epstein Added: 3 years ago
Atrial fibrillation (AF) is the most commonly sustained cardiac arrhythmia observed in clinical practice with a prevalence of over 2,200,000 adults in the US.1 The prevalence of AF increases with age, from <1% among persons <60 years of age, to approximately 10% among those aged ÔëÑ80 years.2 AF is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality… View more
Author(s): Jack Collier , Arthur J Labovitz Added: 3 years ago
The approach to the treatment of a variety of cardiovascular disorders has undergone remarkable change over the past two decades. The use of both percutaneous interventions in patients with acute myocardial infarction and automatic implantable cardiodefibrillators in patients with ventricular arrhythmias represent important examples. The cardiology community is currently in the process of another… View more
Author(s): Michael M McNally , Michael C Stoner Added: 3 years ago
Treatment for blood clots and their life-threatening sequelae has expanded significantly over the past 50 years. Thrombolytic therapy has gained widespread acceptance and use. Advances in technology have led to experiments with catheter-directed thrombolytic therapy in combination with other physical modality delivery systems, such as ultrasound, to improve the efficacy of thrombolytic therapy… View more
Job title: Consultant Cardiologist
DrWael Almahmeed is a Consultant Cardiologist at the Cleveland Clinic Abu Dhabi, United Arab Emirates. Prior to his current position, Dr Almahmeed was Head of Cardiology at the Sheikh Khalifa Medical City in Abu Dhabi. Dr Almahmeed studied medicine at the University of Southampton, in Southampton, UK. He completed his residency in Internal Medicine at the University of British Columbia in… View more
Job title: Director
Dr Claudio Tondo is the Chairman of the Heart Rhythm centre at Centro Cardiologico, University of Milan, Italy. Dr Tondo's interests range from clinical aspects of arrhythmias to genetics. View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 4 years ago
Prof Nicolas van Mieghem & Dr Joost Daemen (Erasmus MC, Rotterdam, NL) preview and discuss the late-breaking trials of ACC 2020. Editor: Mirjam Boros View more
Author(s): Davide Cao Added: 2 years ago
Dr Davide Cao (Icahn School of Medicine at Mount Sinai, US) discusses the key results and impact on clinical practice of the pre-specified analysis of the TWILIGHT trial presented at ESC Congress 2021. TWILIGHT-HBR evaluated the effects of ticagrelor monotherapy versus ticagrelor (Brilinta) plus aspirin on bleeding and ischemic outcomes in a contemporary ARC-defined HBR population undergoing… View more